FIUSEX:NMF-FIUSEX (USD)

MUTUAL FUND | Others |

Last Closing

USD 10.1076

Change

+0.01 (+0.10)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VRGWX Vanguard Russell 1000 Growth I..

-4.36 (-0.53%)

USD 26.28B
XMDYX Mid Cap SPDR 400 Trust Series ..

-5.49 (-0.94%)

USD 19.32B
VRTIX Vanguard Russell 2000 Index Fu..

-3.17 (-0.91%)

USD 10.02B
VRVIX Vanguard Russell 1000 Value In..

-1.60 (-0.48%)

USD 9.85B
VRNIX Vanguard Scottsdale Funds - Va..

-2.73 (-0.50%)

USD 7.05B
VRTTX Vanguard Russell 3000 Index Fu..

-2.75 (-0.52%)

USD 3.51B
XAODX Alpine Total Dynamic Dividend ..

+0.01 (+0.10%)

USD 2.09B
XNUVX Nuveen Municipal Value Fd Inc

+0.01 (+0.11%)

USD 2.06B
VRTGX Vanguard Russell 2000 Growth I..

-4.13 (-1.00%)

USD 1.19B
XJPCX Nuveen Preferred Income Opport..

N/A

USD 0.99B

ETFs Containing FIUSEX

FINX Global X FinTech ETF 7.64 % 0.68 %

-0.25 (0%)

USD 0.33B
IPAY Amplify ETF Trust 6.20 % 0.75 %

-0.65 (0%)

USD 0.34B
CWS AdvisorShares Focused Equ.. 4.44 % 0.68 %

-0.13 (0%)

USD 0.18B
CCOR Core Alternative ETF 3.72 % 1.23 %

-0.02 (0%)

USD 0.07B
ZFIN:CA 3.53 % 0.00 %

N/A

N/A
XAXD:LSE Xtrackers - MSCI AC Asia .. 3.42 % 0.00 %

+0.70 (+0%)

N/A
XAXJ:LSE Xtrackers MSCI AC Asia ex.. 3.42 % 0.00 %

+20.50 (+0%)

N/A
DVOL First Trust Dorsey Wright.. 2.95 % 0.60 %

-0.28 (0%)

USD 0.06B
EBUY:F 2.94 % 0.00 %

N/A

N/A
EBUY:XETRA 2.88 % 0.00 %

N/A

N/A
DGTL:LSE iShares Digitalisation UC.. 2.76 % 0.00 %

-0.16 (0%)

N/A
2B79:XETRA 2.76 % 0.00 %

N/A

N/A
2B79:F 2.76 % 0.00 %

N/A

N/A
DGIT:LSE iShares Digitalisation UC.. 2.71 % 0.00 %

-17.25 (0%)

N/A
NSGE:CA NBI Sustainable Global Eq.. 2.60 % 0.00 %

-0.22 (0%)

CAD 0.53B
BUYB:PA Invesco Global Buyback Ac.. 2.53 % 0.00 %

-0.32 (0%)

USD 0.06B
BBCK:F 2.53 % 0.00 %

N/A

N/A
BBCK:XETRA 2.53 % 0.00 %

N/A

N/A
UNIC:LSE Amundi MSCI Disruptive Te.. 2.35 % 0.00 %

-0.06 (0%)

USD 0.16B
VALQ American Century STOXX U... 2.14 % 0.29 %

-0.24 (0%)

USD 0.24B
IYJ iShares U.S. Industrials .. 1.91 % 0.42 %

-1.35 (0%)

USD 0.94B
KNOW Direxion All Cap Insider .. 1.89 % 0.67 %

+0.02 (+0%)

N/A
EKLD:PA BNP Paribas Easy - MSCI U.. 1.72 % 0.00 %

-0.01 (0%)

USD 0.13B
EKUS:PA BNP Paribas Easy MSCI USA.. 1.72 % 0.00 %

-0.15 (0%)

USD 0.23B
EKUS:XETRA 1.72 % 0.00 %

N/A

N/A
ULVM VictoryShares US Value Mo.. 1.24 % 0.20 %

-0.62 (0%)

USD 0.16B
EMWE:PA BNP Paribas Easy MSCI Wor.. 1.00 % 0.00 %

-0.10 (0%)

USD 1.03B
EWRD:PA BNP Paribas Easy MSCI Wor.. 1.00 % 0.00 %

-0.01 (0%)

USD 0.09B
EMWE:F 1.00 % 0.00 %

N/A

N/A
EMWE:XETRA 1.00 % 0.00 %

N/A

N/A
CFA VictoryShares US 500 Vola.. 0.38 % 0.35 %

-0.43 (0%)

USD 0.54B
CFO VictoryShares US 500 Enha.. 0.37 % 0.35 %

-0.44 (0%)

USD 0.44B
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

-0.09 (0%)

N/A
SBUY:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

-30.50 (0%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials ()

Quarterly Financials ()

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike